Application effects of drug-coated balloon in patients with coronary heart disease treated by percutaneous coronary intervention
Objective:To observe application effects of drug-coated balloon in patients with coronary heart disease treated by percutaneous coronary intervention(PCI).Methods:The clinical data of 70 patients with coronary heart disease treated by PCI in this hospital from April 2022 to April 2023 were retrospectively analyzed.According to different treatment methods,they were divided into control group(n=35)and observation group(n=35).The control group was treated with drug-eluting stent,while the observation group was treated with drug-coated balloon.The clinical efficacy,the cardiac function indexes[left ventricular systolic fraction(LVSF),left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD)]levels before and after the treatment,the incidence of adverse cardiovascular events,the coronary artery restenosis rate,and the recurrence rate of angina pectoris were compared between the two groups.Results:The total effective rate of the observation group was 97.14% (34/35),which was higher than 74.29% (26/35)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of LVSF and LVEF in the two groups were higher than those before the treatment,and those in the observation group were higher than those in the control group;the levels of LVEDD and LVESD in the two groups were lower than those before the treatment,and those in the observation group were lower than those in the control group;and the differences were statistically significant(P<0.05).The incidence of adverse cardiovascular events in the observation group was 2.86% (1/35),which was lower than 22.86% (8/35)in the control group,and the difference was statistically significant(P<0.05).Further,the coronary artery restenosis rate and the recurrence rate of angina pectoris in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusions:The drug-coated balloon in PCI for the patients with coronary heart disease can improve the total effective rate of treatment,improve the levels of cardiac function indicators,and reduce the incidence of adverse cardiovascular events,the coronary restenosis rate and the recurrence rate of angina pectoris.Moreover,it is superior to drug-eluting stent treatment.
万方数据
维普
